Cooperative Agreement NH23IP922550

This $820,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the "CDC Investigations and Technical Assistance" program (CFDA 93.283) will support "Strengthening Routine Immunization and Vaccine Equity (STRIVE)" activities in the Democratic Republic of the Congo and Brazil. The 5-year project, with a period of performance from September 30, 2024 to September 29, 2029, will be implemented by the non-profit organization World Vision...

This Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283), provides $1,980,000.00 to Jhpiego Corp to strengthen immunization program implementation in the Philippines. The 5-year project, commencing on September 30, 2024, aims to improve the delivery of critical immunization services and enhance the overall health system capacity at the subnational level. Jhpiego, a non-profit global health...

This $6,402,000 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) through the Investigations and Technical Assistance program (CFDA 93.283) aims to reinforce immunization systems in the Democratic Republic of Congo, Ethiopia, and Nigeria. The primary awardee, African Field Epidemiology Network LTD (AFENET), is a non-profit organization registered in Uganda that specializes in public health initiatives across sub-Saharan Africa. Over the 5-year award period...

The Fogarty International Center (CFDA 93.989) awarded a $186,254 Project Grant to the Ifakara Health Institute in Tanzania to conduct a study titled "Improving Dog Vaccinations: A Development and Feasibility Study to Pave the Way for Effective, Synchronized Dog Vaccination Campaigns in Africa." The study aims to investigate the potential of synchronized dog vaccination campaigns as an alternative to the traditional team-led approach in East Africa. The project will compare vaccination...

This $220,000 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop and test a novel intervention to improve routine vaccination of hospitalized children. The key components of the "Presumptively Initiating Vaccines and Optimizing Talk for Inpatients (PIVOT-IN)" intervention include: A standardized screening approach to identify vaccine-eligible...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $184,896 in funding to The Children's Hospital of Philadelphia (CHOP) to conduct research on overcoming maternal antibody interference in infant vaccine responses. The key objectives of this 5-year research program are to determine the mechanisms by which mRNA-lipid nanoparticle (mRNA-LNP) vaccines and...

The Centers for Disease Control and Prevention (CDC) awarded a $4,050,000 Cooperative Agreement under the CDC Investigations and Technical Assistance program (CFDA 93.283) to Save The Children Federation, Inc. for the project "STRENGTHENING IMMUNIZATION PROGRAM IMPLEMENTATION IN SUB-NATIONAL CONSEQUENTIAL GEOGRAPHIES - ETHIOPIA". The award period is from Sep 30, 2024 to Sep 29, 2029. The objective of this Cooperative Agreement is to support strengthening immunization program...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1.3M Cooperative Agreement under the Centers for Disease Control and Prevention Investigations and Technical Assistance (CFDA 93.283) program to the Albert B. Sabin Vaccine Institute, Inc. (Sabin Vaccine Institute) to strengthen immunization program implementation in sub-national geographical areas of Brazil. The award, effective September 30, 2024 through September 29, 2029, will support research, surveillance, epidemiological...

This Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop an effective HIV vaccine regimen that elicits both broadly neutralizing antibodies and high-quality T-cell responses. The $7,105,240 award supports a 5-year research program with the University of California, Davis as the prime recipient. The program includes three main projects: Project 1 will examine...

This $250,000 project grant from the U.S. Agency for International Development (USAID), under the Foreign Assistance for Programs Overseas program (CFDA 98.001), will support research into the challenges and enablers of reactive vaccination campaigns in humanitarian settings. The award, made to The Johns Hopkins University, will investigate approaches to improving the effectiveness of responding to outbreaks with vaccines in crisis and conflict environments. The research aims to provide insights...